Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing

Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

Deepest Hole on Project

Three New High-grade Vein Sets at Depth

Two New Top 10 and Three New >100 g/t AuEq*m Intersections

Massive Florida Demand for CyttaCOMMS and Drones Drives Partnership

AZT PROTECT named best "Application Security" solution at Fortress Cybersecurity Awards

Development of a Lithium Ion Conducting Ceramic with leading performance;

Development of an improved separator membrane that utilizes the in-house ceramics;

Plan to start shipping prototypes to a major automaker this calendar year

mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older

Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older